Jasper Therapeutics, Inc. JSPR
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-11-20
Jasper Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 692,980 | $15.7M | 2.48% |
| MILLENNIUM MANAGEMENT LLC | 1,617,531 | $1.4M | 5.78% |
| RENAISSANCE TECHNOLOGIES LLC | 177,500 | $155,526 | 0.63% |
| CITADEL ADVISORS LLC | 74,100 | $64,927 | 0.26% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.